"Michael has done an incredible job since becoming CEO of Aton Pharma. Michael is determined to make life better for those with a rare disease. He, and his company, have made a huge difference in the Wilson disease community. It is my great pleasure to work with him on behalf of our Wilson disease community."
Mary Graper, President of the Wilson Disease Association

"Recently we were very pleased to read your letter informing our son Josh that he had been included in the Aton Patient Assistance Program for Demser for a second year. We are so grateful. We remain convinced of the efficacy of Demser for helping Josh manage his 22q11.2 deletion syndrome. We remain deeply appreciative for your assistance to our son."
Mother of patient in Aton's Donation Program

"Bravo to Aton for identifying and responding to the needs of glaucoma patients who cannot use BAK! Please let me know if you ever need testimony from a glaucoma patient who has taken nearly every glaucoma agent available in an effort to control IOP ... I only discovered the BAK problem after extensive internet searching for clues about my symptoms ... I eventually got (preservative-free) TIMOPTIC in OCUDOSE. Good luck and best wishes."
BLS, PhD, Professor Emerita, University of Wisconsin-Madison